Bizily Scott 4
4 · 4D Molecular Therapeutics, Inc. · Filed Oct 14, 2025
Insider Transaction Report
Form 4
Bizily Scott
Chief Legal Officer
Transactions
- Sale
Common Stock
2025-10-09$10.00/sh−2,408$24,080→ 5,188 total
Footnotes (1)
- [F1]Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 6, 2025.